Clinical Trials Search Results

Results 1-10 of 48 for your search
Show Search Criteria
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 828 locations
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 24 locations
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 15 locations
A Study of Enfortumab Vedotin Plus Pembrolizumab and / or Chemotherapy for Patients With Urothelial Bladder Cancer (EV-103)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 14 locations
Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 10 locations
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 9 locations
Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 11 locations
Atezolizumab, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients with Metastatic and Muscle Invasive Bladder Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 9 locations
1 2 3 4 5 Next >